Abstract
Objective
Treatment of recurrent diseases in patients with cervical or endometrial cancers after primary treatment by radiotherapy is challenging due to limitations of treatment options and success rates. Results are variable with contrasting outcomes and toxicities.
Methods
The authors reviewed all recent evidences and summarized the recent series of studies along with recent advancements and future possibilities.
Results
Surgical options were traditionally limited to extensive resections such as pelvic exenteration with or without intraoperative radiotherapy (IORT) or radical radiotherapy. IORT can be used as an adjunct to surgery in recurrent malignancies with positive margins. Recent interstitial brachytherapy (ISBT) studies for central recurrences have demonstrated a moderate 2 to 3 years local control of ~ 50%. Stereotactic body radiotherapy (SBRT) has also emerged as an attractive and apparently viable alternative, especially in treating relapsed nodes and pelvic sidewall disease, achieving 1- and 2-year local control rates of about 80 and 50%, respectively.
Conclusion
The results of salvage re irradiation are reasonable. More upcoming evidences and ongoing technological innovations will guide us in more effective retreatment and addition to life in this group of patients.
Similar content being viewed by others
References
Haie-Meder C, Chargari C, Rey A, Dumas I, Morice PH, Magne N (2010) MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. RadiotherOncol 96:161–165
Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N et al (2007) Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. RadiotherOncol 83:148–155
Dimopoulos JC, Pötter R, Lang S, Fidarova E, Georg P, Dörr W et al (2009) Dose–effect relationship for local control of cervical cancer by magnetic resonance image guided brachytherapy. Radiother Oncol 93:311–315
Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P et al (2009) Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 75:56–63
Nag S, Gupta N (2000) A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 46:507–513
Nieder C, Milas L, Ang KK (2000) Tissue tolerance to re-irradiation. Semin Radiat Oncol 10:200–209
Nieder C, Langendijk JA, Guckenberger M, Grosu AL (2017) Preserving the legacy of re-irradiation: a narrative review of historical publications. Advances in Radiation Oncology 2:176–182
Greco C, Gribeaudo S, Orecchia R (1996) Radiation therapy of recurrent cervical carcinoma. Noegyogyaszati Onkologia 2:188–192
Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr (1989) Clinical and histopathological factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73:1027–1034
Del Carmen MG, MC-Intyre J, Goodman A (2000) The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies. Oncologist 5:18–25
Barney BM, Petersen IA, Dowdy SC, Bakkum-Gamez JN, Klein KA, Haddock MG (2013) Intraoperative electron beam radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer. Radiat Oncol 8:80
Backes FJ, Billingsley CC, Martin DD, Tierney BJ, Eisenhauer EL, Cohn DE, O’Malley DM, Salani R, Copeland LJ, Fowler JM (2014) Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer? Gynecol Oncol 135:95–99
Calvo FA, Sole CV, Lozano MA, Gonzalez-Bayon L, Gonzalez-Sansegundo C, Alvarez A, Blanco J, Calín A, Lizarraga S, García-Sabrido JL (2013) Intraoperative electron beam radiotherapy and extended surgical resection for gynaecological pelvic recurrent malignancies with and without external beam radiation therapy: long-term outcomes. Gynecol Oncol 130:537–544
Morgia M, Walsh L, Milosevic M, Levin W, Fyles A (2011) Gynaecological malignancies. Reradiation New Frontiers. Nieder C, Langendijk JA. Springer-Verlag Berlin Heidelberg
Puthawala AA, Syed AM, Fleming PA et al (1982) Re-irradiation with interstitial implant for recurrent pelvic malignancies. Cancer 50:2810–2814
Randall ME, Evans L, Greven KM, McCunniff AJ, Doline RM (1993) Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol 48:23–31
Llewelyn M, Taylor A (2017) Re-irradiation of cervical and endometrial cancer. Curr Opin Oncol 29:000
Mahantshetty U, Kalyani N, Engineer R, Chopra S, JamemaS GY et al (2014) Reirradiation using high-dose-rate brachytherapy in recurrent carcinoma of uterine cervix. Brachytherapy 13:548–553
Mabuchi S, Takahashi R, Isohashi F, Yokoi T, Okazawa M, Sasano T, Maruoka S, Anzai M, Yoshioka Y, Ogawa K, Kimura T (2014) Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience. Int J Gynecol Cancer 24:141–148
Amsbaugh MJ, Bhatt N, Hunter T, Gaskins J, Parker L, Metzinger D et al (2014) Computed tomography planned interstitial brachytherapy for recurrent gynecologic cancer. Brachytherapy 14:600–605
Martinez-Monge R, Cambeiro M, Rodriguez-Ruiz ME et al (2014) Phase II trial of image-based high-dose-rate interstitial brachytherapy for previously irradiated gynecologic cancer. Brachytherapy 13:219–224
Badakh DK, Grover AH (2009) Reirradiation with HDR brachytherapy implant in recurrent carcinoma cervix. J Cancer Res Ther 5:24–30
Zolciak-Siwinska A, Bijok M, Jonska-Gmyrek J, Kawczynska M, Kepka L, Bujko K, Michalski W (2014) HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk. Gynecologic Oncology 132:93–97
Feddock J, Cheek D, Steber C, Edward J, Slone S, Luo W et al (2017) Reirradiation using permanent interstitial brachytherapy: a potentially durable technique for salvaging recurrent pelvic malignancies. Int J Radiat Oncol Biol Phys 99:1225–1233
Umezawa R, Naoya M, Satoshi N, Akihisa W, Hiroyuki O, Keisuke T et al (2018) Image-guided interstitial high-dose-rate brachytherapy for locally recurrent uterine cervical cancer: a single-institution study. Brachytherapy 17:368–376
Okazawa K, Yuasa-Nakagawa K, Yoshimura R, Shibuya H (2013) Permanent interstitial re-irradiation with Au-198 seeds in patients with post-radiation locally recurrent uterine carcinoma. J Radiat Res 54:299–306
Deodato F, Macchia G, Grimaldi L, Ferrandina G, Lorusso D, Salutari V, Cilla S, Valentini V, Cellini N, Piermattei A, Scambia G, Morganti AG (2009) Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep 22:415–419
Dewas S, Bibault JE, Mirabel X, Nickers P, Castelain B, Lacornerie T, Jarraya H, Lartigau E (2011) Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results. Radiat Oncol 6:77
Abusaris H, Hoogeman M, Nuyttens JJ (2012) Re-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region. Technol Cancer Res Treat 11:591–597
Yazici G, Ceygiz M, Ozyigit G et al (2013) Salvage stereotactic body radiosurgery in the management of recurrent gynaecological cancer. Int J Hematol Oncol 23:7–12
Park HJ, Chang AR, Seo Y, Cho CK, Jang WI, Kim MS, Choi C (2015) Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a cooperative study of the Korean Radiation Oncology Group (KROG 14-11). Anticancer Res 35:5103–5110
Seo Y, Kim MS, Yoo HJ, Jang WI, Rhu SY, Choi SC, Kim MH, Kim BJ, Lee DH, Cho CK (2016) Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: feasibility and complication. Asia Pacific J Clin Oncol 12:e280–e288
Liu ZS, Guo J, Zhao YZ, Lin X, Chen B, Zhang M, Li JM, Ren XJ, Zhang BY, Wang TJ (2016) Salvage interstitial brachytherapy based on computed tomography for recurrent cervical cancer after radical hysterectomy and adjuvant radiation therapy: case presentations and introduction of the technique. J Contemp Brachytherapy 8:415–421
Banerjee S, Kataria T, Gupta D, Goyal S, Bisht SS, Basu T, Abhishek A (2017) Use of ultrasound in image-guided high-dose-rate brachytherapy: enumerations and arguments. J Contemp Brachytherapy 9:146–150
Herrera FG, Prior JO (2013) The role of PET/CT in cervical cancer. Front Oncol 3:34
Nieder C, Andratschke NH, Grosu AL (2013) Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles. Am J Cancer Res 3:152–158
Viswanathan AN, Damato AL, Nguyen PL (2013) Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers. J Clin Oncol 31:e446–e447
Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH (2007) Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 17:121–130
Verma V, Simone CB II, Wahl AO, Beriwal S, Meheta MP (2015) Proton radiotherapy for gynecologic neoplasms. Acta Oncol 55:1257–1265
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Statement of informed consent was not applicable since the manuscript does not contain any patient data.
Rights and permissions
About this article
Cite this article
Banerjee, S., Goyal, S., Kataria, T. et al. Re-irradiation in gynecological cancers, present experiences and future hopes. J Radiat Oncol 7, 205–211 (2018). https://doi.org/10.1007/s13566-018-0355-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13566-018-0355-6